FibroGen Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$188M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • FibroGen's estimated annual revenue is currently $74.4M per year.(?)
  • FibroGen's estimated revenue per employee is $155,000
  • FibroGen's total funding is $188M.

Employee Data

  • FibroGen has 480 Employees.(?)
  • FibroGen currently has 1 job openings.

FibroGen has developed the only commercially viable method known to produce human collagen and human gelatin in recombinant systems. FibroGen will exploit this technology by becoming both a bulk product supplier for the pharmaceutical and medical device industries as well as a developer and commercializer of injectable products, wound management products, and gelatin stabilizers. FibroGen's corporate collaborations include a partnership with Taisho Pharmaceutical Company of Japan to discover and develop human monoclonal antibody therapeutics for renal fibrosis and chronic transplant rejection.